TUCATINIB for Breast cancer female: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 1,890 adverse event reports in the FDA FAERS database where TUCATINIB was used for Breast cancer female.
Most Reported Side Effects for TUCATINIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Diarrhoea | 1,587 | 26.3% | 73 | 406 |
| Nausea | 862 | 14.3% | 29 | 273 |
| Fatigue | 843 | 14.0% | 49 | 216 |
| Vomiting | 483 | 8.0% | 24 | 204 |
| Death | 400 | 6.6% | 399 | 88 |
| Off label use | 392 | 6.5% | 31 | 112 |
| Malignant neoplasm progression | 361 | 6.0% | 37 | 26 |
| Palmar-plantar erythrodysaesthesia syndrome | 355 | 5.9% | 16 | 49 |
| Product dose omission issue | 332 | 5.5% | 19 | 122 |
| Asthenia | 322 | 5.3% | 34 | 134 |
| Decreased appetite | 286 | 4.7% | 16 | 67 |
| Metastases to central nervous system | 270 | 4.5% | 26 | 61 |
| Disease progression | 268 | 4.4% | 40 | 62 |
| Dehydration | 239 | 4.0% | 9 | 154 |
| Neoplasm progression | 237 | 3.9% | 35 | 37 |
Other Indications for TUCATINIB
Her2 positive breast cancer (993)
Product used for unknown indication (825)
Breast cancer metastatic (738)
Breast cancer (552)
Metastases to central nervous system (77)
Neoplasm malignant (57)
Colorectal cancer metastatic (52)
Colon cancer (49)
Invasive breast carcinoma (38)
Invasive ductal breast carcinoma (38)
Other Drugs Used for Breast cancer female
PALBOCICLIB (17,915)
DOCETAXEL (12,384)
ABEMACICLIB (3,576)
CAPECITABINE (2,576)
CYCLOPHOSPHAMIDE (2,547)
FULVESTRANT (1,292)
EPIRUBICIN (1,236)
TRASTUZUMAB (1,068)
PACLITAXEL (887)
EVEROLIMUS (775)